Company ProfilePremium

Roto-Gro International Limited

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Roto-Gro International Limited - Company showcase

Year Founded & Workforce

2015

Roto-Gro International Limited logo

Roto-Gro International Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Roto-Gro International Limited Overview

Roto-Gro International was a sub-scale Australian-listed, Canadian-operated agricultural technology company. Its core asset was a patented stackable, rotatable hydroponic "Rotational Garden System". In this design, plants grow on the inside of a slowly revolving cylinder around a central light source, which multiplies canopy area per square metre of floor space. The company aimed to commercialise the technology for two markets: licensed (lawful) cannabis cultivation and indoor vertical farming of perishable foods. It sold three things around the hardware: fertigation (automated nutrient delivery), iGrow control software, and growing-management services. Between its A$3.6M IPO in February 2017 and 2022, it never achieved more than A$1.14M of annual sales. It accumulated A$37.3M of losses and relied entirely on equity and convertible-note funding. The Canadian operating subsidiaries entered bankruptcy on 31 May 2022, and the listed parent lost control of every operating asset. Today it is a delisted, asset-less shell (net liabilities A$13,128 at 30 June 2022) facing deregistration.


Company's own description (latest annual report)

The FY2022 Annual Report (lodged 31 August 2023) describes the principal activity, until 31 May 2022, as the production and sale of patented and proprietary Rotational Garden Systems (the "RotoGro Garden Systems"). It also covered the sale and production of advanced automated nutrient delivery and water management systems (the "Fertigation Systems"). The report states that the company lost effective control of its subsidiaries when a bankruptcy trustee was appointed to the Canadian operating subsidiaries. The principal activity therefore ceased on 31 May 2022. In the segment note, the group described itself as operating across the agricultural industry, providing technology and cultivation solutions for advanced indoor hydroponic growing applications.

Independent characterisation

RotoGro was, in substance, a pre-commercial hardware-plus-IP venture. Commercial traction never matched its announced pipeline. Its business model evolved through three phases.

  1. Equipment vendor (FY2017–FY2019). It sold rotary garden units into licensed cannabis facilities in Canada, such as the A$2.3M purchase order announced 4 April 2018. In 2018 it acquired Nevada-based Hanson Fertigation to add a water-treatment and nutrient-management business line. Sales peaked at A$1.14M in FY2019 (FY2021 Annual Report, five-year summary).

  2. Attempted vertical integration (FY2019–FY2020). It tried to become a cannabis cultivator and processor in its own right through two deals. One was the CAD 11M agreement to acquire Supra THC Services Inc. (and its Health Canada Dealer's Licence) from Valens GroWorks, announced 29 October 2018. The other was a perishable-foods venture with Gibio Inc. Both were unwound or written off. The Gibio investment was written off in FY2020 (A$439,897). The US fertigation subsidiary was placed into voluntary administration and dissolved on 23 June 2020.

  3. Asset-light licensing (FY2021–FY2022). Management described the strategy as "less capital-intensive business partnerships and collaborations" (Verity Greens announcement, December 2020). This rested on three agreements:

    • an A$10M Technology Licence Agreement with Verity Greens Inc., covering technology sales, annual software licence fees, manufacturing fees, and a 20-year net profit share;

    • a CAD 1.903M purchase-and-sale agreement with Canniberia LDA (Portugal);

    • a Growing Management Services Agreement with Canniberia LDA, providing for a 25% share of EBITDA from cannabis sales. None of these produced recognised revenue before the operating subsidiaries failed. FY2021 sales were nil and FY2022 sales were A$27,117.

Revenue model mix

Revenue streamDescriptionEvidence of realisation
Product sales (hardware)RotoGro Garden Systems (Model 420, Model 710), fertigation / nutrient management systemsFY2018 A$464k; FY2019 A$1.14M; FY2020 A$679k (unit sales) plus A$226k fertigation (discontinued); FY2021 nil; FY2022 A$27k
Software licensingiGrow Enterprise Edition; "RotoGro Facility Edition"; annual licence fees under the Verity Greens TLANo software revenue separately disclosed
Manufacturing / technology licensingManufacturing and technology-use licences (Verity Greens)No revenue recognised
Services / profit shareGrowing management services (Canniberia: 25% of EBITDA); design and fit-out servicesNo revenue recognised
Government grants (other income)COVID-19 subsidies, mainly the Canada Emergency Wage SubsidyFY2020 A$170k; FY2021 A$519k; FY2022 A$104k

Value-chain position, customers and end-markets

Value-chain position: Upstream cultivation-infrastructure supplier (capital equipment, controls, IP) to growers. In 2018–2019 it attempted to move downstream into cultivation and processing.

Customer types: - Licensed cannabis producers in Canada, such as Wolf Island Cannabis Inc. (Ontario);

  • prospective licensed producers in Europe, such as Canniberia LDA (Portugal);

  • indoor vertical-farm operators, such as Verity Greens Inc. (Canada);

  • fresh-produce growers, such as Fresh Leaf (herb trials in Canada and Australia, under an MOU);

  • in the Hanson era, Nevada cannabis facilities, viticulture and perishable-food growers.

End-markets: Lawful (medical and adult-use) cannabis, with Canada as the core market after legalisation on 17 October 2018. Controlled-environment agriculture / indoor vertical farming of leafy greens, herbs and fruiting crops. Space agriculture as a demonstration niche (NASA/CSA Deep Space Food Challenge, August 2021).

Strategy

Stated strategy (themes from FY2021 Annual Report and investor materials — the last period of active strategy)

  1. Pioneer of rotational garden systems in indoor vertical farming. Defend and expand the patent portfolio (Australian patent grant; RavenQuest settlement; three US provisional filings).

  2. Asset-light commercialisation. Pursue "less capital-intensive business partnerships and collaborations" through technology licences, recurring software fees and profit shares rather than owning cultivation facilities (Verity Greens TLA, December 2020).

  3. Dual end-market focus. Target lawful cannabis (Model 420; Canniberia; Wolf Island) and perishable foods (Model 710; Verity Greens; Fresh Leaf), with a sales pipeline across the USA, Europe and Australia.

  4. Full-facility automation. Combine Facility Edition software, AGVs, LED lighting and direct-injection feed to cut labour, power and water costs.

  5. Capital-markets access. Plan a CSE dual listing for North American valuation comparables and capital access (2021).

Initiatives in the last 24 months (Oct 2024 – Oct 2026)

None. The company has had no operations since 31 May 2022 and no ASX listing since 1 March 2024. Its last known periodic report was the 31 January 2024 quarterly (Appendix 4C). The only corporate event in the window is the ASIC strike-off action initiated 6 August 2026 (delisted.com.au). No restructuring proposal, recapitalisation, reverse takeover, or deed of company arrangement has been disclosed.

Last disclosed recovery strategy (FY2022 Annual Report, going-concern note)

The directors stated that continuing as a going concern depended on three things:

  • raising equity from capital markets;

  • curtailing corporate overheads;

  • acquiring additional assets and attracting capital "to secure the future of the Company" (a shell-reuse / recapitalisation strategy).

No such transaction was announced before delisting.

Guidance and medium-term targets

Not publicly disclosed. The FY2021 report omitted likely developments to avoid "unreasonable prejudice". The company never issued financial guidance. The only quantitative targets were the CEO performance hurdles in the 2019 Clode agreement, none of which were met:

  • A$5M cumulative contracted sales by 31 Dec 2020;

  • A$10M by 31 Dec 2021;

  • A$20M by 31 Dec 2022;

  • a first joint-venture order of at least 100 eight-foot rotational gardens by 31 Dec 2020.

ESG and sustainability commitments

None formally stated. The implicit sustainability thesis was lower water and power use per kilogram of produce versus other indoor farming systems (FY2021 Annual Report R&D section). No quantified targets were set.

Products & Services

Because the group never reported product segments, the catalogue is organised by product family. Pricing was not publicly disclosed except where noted.

Product Portfolio

#Product / offeringDescription & key capabilitiesTarget customerLaunch / latest versionPricing (if disclosed)
1

RotoGro Rotational Garden System (core patented platform)

Stackable, modular, rotatable hydroponic garden. Plant trays mount on rotating rails around a central light, so canopy area per floor square metre is multiplied. Protected by Canadian Patent 2,908,184 (20-year term from filing; ownership confirmed in the FY2021 RavenQuest settlement) and Australian Patent 2015243012

Licensed cannabis producers; vertical farms

Platform from 2015; patents granted by FY2021

n/d per unit. Fresh Leaf MOU implies ~A$25,000 for one unit (FY2021 Annual Report)

2

Model 420 / "RotoGro 420 IT System"

Cannabis-optimised rotational garden. Company trials reported 7–9 lb per system every 60 days with consistent THC/CBD (Nov 2018 operational update)

Licensed cannabis cultivators

Commercial from ~2017–2018; LED control features added FY2021

—
3

Model 710 Garden System

Perishable-foods variant (leafy greens, herbs; trials of strawberries, bok choy, peppers, tomatoes, snacking cucumbers). Integrates proprietary LED lighting and a direct-injection feed system; management claimed lower power and water use and higher yield per m² (FY2021 Annual Report). Basis of the Verity Greens order (624 units, potentially 1,872)

Indoor vertical farms; produce growers

Featured from Dec 2020; six-stacked automation test units FY2021

n/d. Verity TLA headline value A$10M

4

Supporting automation technology

RotoGro-designed elevator systems, motorised actuators and tray handling (Dec 2020 investor material)

Large-scale vertical farms

FY2021

—
5

Automated Guided Vehicles (AGVs)

In-house AGVs for automated tray insertion and removal on stacked Model 710s; development with international automation engineering firms

Full-facility automation buyers

Testing FY2021; not commercialised

—
6

Fertigation Systems / Plant Nutrient Management System

Automated nutrient delivery and water management. Originated with Hanson Fertigation's "patent-pending fully-automated nutrient delivery system" (2018). Integrated with iGrow to automate whole feeding schedules (FY2021)

Cannabis, greenhouse, field, viticulture growers

Acquired 2018; US business dissolved June 2020; integrated system retained in Canada

n/d. Fertigation sales A$225.5k in FY2020

7

Water treatment services (Hanson legacy)

Water treatment and fertigation design, installation and service. Hanson had served more than 12 licensed cannabis facilities in Nevada

Nevada growers

2018–2020

—
8

iGrow® Enterprise Edition software

Automation, monitoring and configuration of the cultivation process. FY2021 redesign added a new interface, security layers, email alerts, and LED control for Models 710 and 420

System owners

Redesigned FY2021

Annual licence fees contemplated under the Verity TLA; amount n/d

9

RotoGro Facility Edition software

Facility-scale control layer for Model 710 automation, AGVs and tray handling

Vertical farm operators

Under commercialisation FY2021

—
10

Proprietary LED lighting solution

LED system designed for the rotational geometry

Model 710/420 users

FY2021 trials

—
11

Direct-injection feed system / plant tray feed system

Feed nozzle and plant tray feed system (US provisional 63/088,597, also reported as 63/088,598)

System users

Filed FY2021

—
12

Growing Management Services

Dedicated cultivation management in exchange for a profit share (Canniberia: 25% of EBITDA from cannabis flower sales)

Licence holders lacking cultivation know-how

Agreement FY2021; conditional on licence

Profit share

13

Technology & manufacturing licences

Rights to use and manufacture RotoGro technology in a field of use (Verity Greens: perishable foods; 20-year initial term with net profit share)

Licensees

Dec 2020

A$10M headline; components n/d

14

Design & fit-out services

Facility design and fit-out solutions for cannabis and perishable-food facilities

New facilities

2018 onward

—
15

Proprietary genetics – "Black Romulan" cannabis strain

Strain developed for the 420 IT System. Compact buds and mild aroma; THC reported above 20% in initial tests (Dec-2020 quarter)

Cannabis cultivators

Dec 2020 quarter

Not commercialised

16

Space-agriculture application

Adaptation for the NASA/CSA Deep Space Food Challenge (Phase 1)

Space agencies (demonstration)

Aug 2021

—

Financial Narrative

The analysis uses the five most recent audited years (FY2018–FY2022). FY2022 accounts carry an audit disclaimer of opinion and consolidate subsidiaries only to 31 December 2021. FY2023 accounts were not located.

Income statement

Blank cells = not publicly disclosed in reviewed sources: Sources: FY2021 Annual Report (five-year summary FY2017–FY2021; FY2020–FY2021 income statements); FY2022 Annual Report (five-year summary FY2018–FY2022; FY2022 income statement).

FY2020 EPS: −11.20c is the continuing-operations figure used in the five-year table; total EPS including discontinued operations was −11.39c.

Discrepancy: the FY2020 five-year table gives EBITDA of −A$14.28M, while the FY2021 segment note gives −A$14.72M for FY2020 (including discontinued operations). Both are shown in the respective filings.

FY2022 EBITDA (−A$12.29M) includes the A$8.41M impairment and A$1.36M deconsolidation expense.

Margins and growth

Revenue CAGR, FY2018–FY2022: approximately −50.8% per year (A$464k → A$27k). FY2017 sales were A$3,276, so the FY2017–FY2019 build-up was rapid from a negligible base, but it reversed after FY2019. Margins are not meaningful in FY2021 because there was no revenue.

Commentary.

The income statement shows a company that never escaped the commercialisation valley. Revenue peaked in FY2019 at A$1.14M. That year combined the Canadian equipment orders (including the A$2.3M order announced in April 2018, recognised in part) with first-year Hanson fertigation revenue.

FY2020 shows the first inflection. Sales fell 40% and the company sold units below cost (gross loss A$358k on A$679k of sales, implying −52.8% gross margin). It also impaired A$9.66M of intangibles and wrote off the Gibio investment.

FY2021 was the "licensing pivot" year, with zero sales. The loss narrowed to A$4.61M only because there were no impairments. A$0.90M of the cost base was share-based payments and A$0.50M was convertible-note finance costs.

FY2022 crystallised the collapse. An A$8.01M impairment of the cash-generating unit at 31 December 2021, plus A$0.40M at 30 June 2022 and A$1.36M of deconsolidation expense, wiped out all remaining non-current assets.

Cumulative losses reported over FY2017–FY2022 total ≈A$43.5M. Accumulated losses on the balance sheet were A$37.26M at 30 June 2022, after A$6.9M of option and right lapse transfers.

Balance sheet

FY2019 closing equity was A$22,034k and closing cash A$3,009k (FY2021 Annual Report statement of changes in equity and cash flow). Other FY2018–FY2019 balance-sheet lines were not publicly disclosed in reviewed sources. Net debt excluding leases was −A$345.5k (FY2020), −A$1,638.4k (FY2021) and −A$116.2k (FY2022). MarketScreener reports net debt of −A$1.44M (FY2021) and −A$116k (FY2022), consistent with the lease-inclusive figures.

Commentary.

No borrowings: The group never carried bank debt; the only financing liabilities were property and vehicle leases in Canada.

Asset base was almost entirely capitalised IP: Intangibles were 76% of total assets in FY2020 and 66% in FY2021, so asset value depended on the IP being commercialised.

Contract liabilities: These are customer deposits (A$524.6k at FY2021, rising to A$751.1k before deconsolidation, including the Wolf Island deposit). They were extinguished on deconsolidation, which implies customers who prepaid were left as creditors of the bankrupt Canadian subsidiary.

Year-end FY2022: The parent held A$116k of cash against A$169k of payables, giving negative net assets of A$13,128.

Cash flow

Commentary.

  • Over FY2020–FY2022 the business burned ≈A$9.96M of free cash flow and funded it almost entirely from new equity (A$7.45M) and a convertible note (A$1.25M).

  • The FY2022 cash statement is notable: A$1.197M of cash, raised largely in the July 2021 A$2.2M placement, sat in the Canadian subsidiaries. It was derecognised on loss of control, so shareholders who funded the July 2021 placement effectively saw those funds absorbed into the bankruptcy.

Ratios

Not meaningful or not computable:

  • ROIC: negative NOPAT and an IP-dominated capital base.

  • Net debt / EBITDA: net cash and negative EBITDA.

  • Cash conversion cycle: no receivables or revenue base in FY2021; COGS-based inventory days are distorted.

Ratio definitions: ROE uses average equity. ROA uses average total assets (FY2019 total assets n/d). The FY2022 ROE of −241.7% matches the aggregator Wisesheets (−241.74%).

Trend synthesis.

  • The only "improvement" was the FY2021 current ratio, driven by equity raises.

  • The defining inflections were the FY2020 impairment, which recognised that the cannabis-equipment thesis was not delivering, and the FY2022 bankruptcy and deconsolidation, which ended the business.

  • Drivers throughout were:

    • sub-scale sales against a fixed Canadian R&D and manufacturing base;

    • heavy reliance on equity compensation (share-based payments of A$708k, A$900k and A$302k in FY2020–FY2022);

    • failure to convert headline agreements (Verity A$10M; Canniberia A$2.03M) into delivered orders.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionFunctionStatus

Roto-Gro International Limited

Australia

Listed parent / holding

Delisted 1 Mar 2024; strike-off initiated Aug 2026

Roto-Gro World Wide (Canada) Inc.

Canada

Principal operating company (manufacturing, R&D, sales)

Bankrupt 31 May 2022; deconsolidated

Roto-Gro World Wide Inc.

Mauritius → British Virgin Islands (15 Oct 2021)

Holder of group intangible assets

Deconsolidated (no records available to directors)

Roto-Gro Inc.

Canada

Original patent-owning company (Australian Patent 2015243012)

Deconsolidated

Roto-Gro International Inc.

Canada

Subsidiary

Deconsolidated

Roto-Gro Intellectual Property Inc. (Roto-Gro IP Inc.)

Canada

IP subsidiary

Deconsolidated

Roto-Gro Technology Inc.

Canada

Technology subsidiary

Deconsolidated

Global Fertigation Solutions Inc. (ex-Hanson Fertigation assets)

USA (Nevada)

Fertigation / water treatment

Voluntary administration; dissolved 23 Jun 2020

Revenue by Segment

Segment (geography)FY2020FY2021FY2022

Australia total revenue (AUD K)

10.410.10.2

Canada total revenue (AUD K)

956.3510.5131.4

USA total revenue (AUD K)

225.500

Mauritius/BVI total revenue (AUD K)

000

Group total revenue (AUD K)

1,192.2520.7131.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment — Canada – RotoGro unit sales

SegmentFY2020FY2021FY2022

Canada – RotoGro unit sales (AUD K)

678.6027.1

USA – fertigation sales, discontinued (AUD K)

225.500

Total customer sales incl. discontinued (AUD K)

904.1027.1

Revenue by Segment — Australia

SegmentFY2020FY2021FY2022

Australia (AUD K)

-1,467.2-2,049.1-10,793.6

Canada (AUD K)

-2,806.5-2,473.9-1,885.4

Mauritius/BVI (AUD K)

-11,339.7-85.96.7

USA (AUD K)

-262.700

Group (AUD K)

-15,876.2-4,608.9-12,672.3

Income Statement and Per-Share Data

MetricFY2018FY2019FY2020FY2021FY2022

Sales revenue (AUD K)

464.11,139.8678.6027.1

Other income incl. grants (AUD K)

——288.1520.7104.5

Cost of goods sold (AUD K)

——-1,036.7-10.7-189.2

Gross profit (AUD K)

——-358.1-10.7-162.1

EBITDA as reported (AUD K)

-2,728.7-5,425.9-14,277.6-3,356.7-12,292.3

Depreciation & amortisation (AUD K)

——-1,158.6-753.3-379.9

EBIT computed, continuing (AUD K)

——-15,613.5-4,110.0-12,672.3

Finance costs (AUD K)

——0-498.90

Pre-tax loss, continuing (AUD K)

——-15,613.5-4,608.9-12,672.3

Net loss attributable (AUD K)

-3,191.7-6,171.8-15,876.2-4,608.9-12,672.3

Basic EPS (A$ cents)

-3.82-4.80-11.20-2.20-3.74

Diluted EPS (A$ cents)

-3.82-4.80-11.20-2.20-3.74

Dividends per share (A$ cents)

00000

Margin Analysis (%)

MetricFY2018FY2019FY2020FY2021FY2022

Revenue growth YoY (%)

—145.6-40.5-100.0—

Gross margin (%)

——-52.8—-597.7

EBITDA margin (%)

-588.0-476.0-2,104.0—-45,331

Operating (EBIT) margin (%)

——-2,300.9—-46,732

Net margin (%)

-687.7-541.5-2,339.5—-46,732

Balance Sheet

MetricFY2020FY2021FY2022

Total assets (AUD K)

10,575.111,596.3155.4

Cash & equivalents (AUD K)

345.51,638.4116.2

Inventories (AUD K)

624.6895.20

Plant & equipment (AUD K)

1,033.71,067.40

Intangibles – IP, patents & trademarks (AUD K)

8,037.47,605.30

Goodwill (AUD K)

000

Short-term borrowings (AUD K)

000

Long-term borrowings (AUD K)

000

Lease liabilities current (AUD K)

143.8151.30

Lease liabilities non-current (AUD K)

210.949.60

Net debt incl. leases (AUD K)

9.2-1,437.4-116.2

Contract liabilities / customer deposits (AUD K)

520.7524.60

Total liabilities (AUD K)

1,574.41,099.0168.6

Total equity (AUD K)

9,000.810,497.3-13.1

Working capital (AUD K)

-179.21,695.7-13.1

Cash Flow

MetricFY2020FY2021FY2022

Receipts from customers (AUD K)

1,132.40242.2

Operating cash flow (AUD K)

-4,177.2-2,874.7-2,161.7

Capex – plant & equipment (AUD K)

-415.5-230.8-99.0

Free cash flow (AUD K)

-4,592.7-3,105.6-2,260.7

Equity issued, net (AUD K)

2,119.23,309.82,022.3

Convertible note proceeds (AUD K)

01,250.00

Dividends paid (AUD K)

000

Share buybacks (AUD K)

000

Cash derecognised on deconsolidation (AUD K)

00-1,197.0

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2020FY2021FY2022

ROE (%)

-102.3-47.3-241.7

ROA (%)

—-41.6-215.7

Current ratio (x)

0.872.620.92

Debt / equity excl. leases (x)

000

Lease liabilities / equity (%)

3.91.90

Interest coverage, EBIT / finance costs (x)

—-8.2—

Asset turnover (x)

—00.005

Revenue by Region

RegionFY2020FY2021FY2022

Canada (AUD K)

678.6027.1

USA (AUD K)

225.500

Australia (AUD K)

000

Europe (AUD K)

000

Geographic Revenue

RegionFY2021 YoY (%)FY2022 YoY (%)

Canada

-100

n/m (from nil)

USA

-100 (operations dissolved 23 Jun 2020)

—

Product Lines

Product lineCanada (AUD K)USA (AUD K)Total (AUD K)

RotoGro unit sales

678.60678.6

Fertigation sales (discontinued)

0225.5225.5

Share Price

MetricFY2017FY2018FY2019FY2020FY2021

Share price at 30 June (AUD)

0.350.360.160.050.04

Return metric

Return metricValue

FY2018 → FY2021 (3 years)

−88.9%

FY2017 → FY2021 (4 years)

−88.6%

IPO (Feb 2017) → last trade (~Feb 2022)

≈ −97% (A$0.355 June 2017 trade → ≈A$0.011)

Pearler 5-year average annual capital growth (aggregator)

−18.0%

1-, 3- and 5-year returns to Oct 2026

Not applicable: no quotation since Feb 2022; delisted Mar 2024

Share Count (millions) and Capital Markets Data

MetricFY2020FY2021FY2022

Ordinary shares on issue at 30 June (millions)

149.0279.7342.6

Issued capital (AUD K)

28,808.034,400.736,240.9

Share Price & Returns

DateInstrumentAmount (AUD)Price (AUD)

Feb 2017

IPO (Barclay Wells)

3.6M

—

2018 (n/d)

Placement

4.56M

—

31 Dec 2019

Placement (with A$0.20 options)

——

Aug–Oct 2020

Obsidian convertible notes

1.25M

Conversions at ≈A$0.039–0.044

30 Nov 2020

Placement (Peak)

1.53M

0.04

2 Mar 2021

Placement

2.00M

0.05

23 Jul 2021

Placement (EverBlu)

2.20M

0.035

26 Sep 2022

Placement

0.05M

0.001

Attribute Details

AttributeStatus

Dividends

None ever paid, recommended or declared

Buyback authorisations

None ("no current on-market share buy-back", FY2022 Note 22)

Credit ratings (Moody's / S&P / Fitch)

Not rated

Debt maturity profile

No debt. Lease liabilities were nil after deconsolidation

Analyst consensus

None. Coverage limited to paid or sponsored content (Stockhead advertiser disclosures; Kalkine)

Analyst Conclusions

Management guidance

None. The last forward-looking statement was in the FY2022 going-concern note (31 Aug 2023): the directors believed the entity could raise capital and acquire new assets. No such transaction followed. There is no consensus.

Bull-case arguments (residual and theoretical)

  1. Clean, debt-free shell. The entity carried no borrowings and only A$169k of liabilities (FY2022). A promoter could theoretically revive it via creditor settlement and recapitalisation before strike-off is completed.

  2. Validated IP may retain value elsewhere. A court-confirmed Canadian patent and a granted Australian patent could be monetised by whoever now controls them, though this value likely accrues to the bankruptcy estate rather than RGI shareholders.

  3. Accumulated tax losses. About A$37.3M of accumulated losses could theoretically be valuable. Use is heavily constrained by continuity-of-ownership and same-business tests, and value would require the entity to survive.

Bear-case arguments (dominant)

  1. No operating assets, no listing, no cash flow. All subsidiaries were deconsolidated, all intangibles impaired to nil, and the ASX listing removed on 1 Mar 2024.

  2. Deregistration in progress. ASIC strike-off action was initiated on 6 Aug 2026. Completion would dissolve the company and extinguish shares.

  3. Track record of non-conversion. Over five years, headline agreements totalling more than A$12M (Verity A$10M; Canniberia A$2.03M) produced no recognised revenue. Cumulative reported losses of ≈A$43.5M were funded by dilutive equity. The audit disclaimer means even the final accounts cannot be relied upon.

Catalysts and monitorables (next 12 months)

  • ASIC deregistration notice publication, or any objection or reinstatement application.

  • Any lodgement of outstanding financial reports (FY2023 onward), or any notice of a creditors' scheme or recapitalisation proposal.

  • Disposition of RotoGro patents by the Canadian bankruptcy trustee.

  • Any shareholder communication via the registry (Computershare) regarding residual value.

Concluding analyst verdict

Roto-Gro International Limited is a case study in why a credible patent is not enough for a hardware-led agtech business. Product-market fit, unit economics and patient capital also matter. The company's core idea, a stackable rotating hydroponic garden that multiplies canopy per square metre, was genuine and defensible. RotoGro won a Federal Court-confirmed outcome over the Canadian patent and secured an Australian grant. But from its A$3.6M IPO in February 2017 to the bankruptcy of its Canadian operating subsidiary on 31 May 2022, the business never generated more than A$1.14M of annual sales. In its last full year of trading at scale (FY2020) it sold units at a negative gross margin.

Strategy oscillated: equipment vendor, then aspiring cannabis cultivator (Supra THC, Gibio, 420 Inc.), then asset-light licensor (Verity Greens). Each pivot was funded by small, heavily optioned placements and a toxic-style convertible note. Each headline agreement was conditional on counterparties who themselves lacked funding. The vertical-farming capital drought from 2022 and Canadian cannabis oversupply removed any remaining path.

The governance signals deteriorated in step. Directors waived fees. The CEO received 27 million options weeks before the collapse. Shareholders delivered a remuneration first strike. The final accounts were lodged 14 months late with an audit disclaimer, showing negative net assets of A$13,128. The ASX removed the company on 1 March 2024, and ASIC initiated strike-off action on 6 August 2026.

Verdict: The equity should be regarded as having no realistic recoverable value. For investors, the residual relevance is limited to tax-loss documentation and monitoring the deregistration process. For industry observers, the useful lesson is the reminder that patent quality, headline contract values and yield-per-square-metre claims are weak predictors of commercial success in controlled-environment agriculture. Rating: Not investable / defunct entity.


End of dossier. Figures are drawn from the company's ASX-lodged Appendix 4E / annual reports for FY2021 (31 Aug 2021) and FY2022 (31 Aug 2023), the December 2020 quarterly report, and ASX notices (22 Jan 2024; 1 Mar 2024), supplemented by Valens GroWorks/CNW, Stockhead, Business News (WA), Business News Australia, Kalkine, MarketScreener, MarketBeat, Market Index, Wisesheets and delisted.com.au. Items marked n/d or left blank were not publicly disclosed in the sources reviewed. The FY2022 financial statements are subject to an auditor's disclaimer of opinion.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenureBackground / educationOther listed directorshipsInterest in shares

Michael Carli

Non-Executive Chairman (formerly Managing Director)

Since inception (2015)

Toronto-area corporate, commercial and IP lawyer for 30+ years. BA (York University); JD (University of Western Ontario). Vice-Chair, Easter Seals Ontario; former Chairman, Villanova College; member of the Law Society of Ontario and the Intellectual Property Institute of Canada. Director and President of all Canadian subsidiaries

—

164,994 (post-consolidation)

Terry Gardiner

Non-Executive Director

Since IPO era (about 2017)

20+ years in capital markets, stockbroking and derivatives. Director, Barclay Wells Ltd (IPO manager)

Cazaly Resources (CAZ), Galan Lithium (GLN), Charger Metals (CHR, Chair)

4,903 (post-consolidation)

Peter Hatfull

Executive Director (appointed NED 19 Apr 2022); Company Secretary (from 5 May 2022)

2022–

40+ years in board and executive roles; business optimisation, capital raising, restructuring

Melodial Global Health (ME1). Former: Pivotal Metals (PVT, resigned Aug 2023), Roots Sustainable Agricultural Technologies (ROO, resigned Aug 2022), eSense Labs (ESE, delisted Sep 2021)

Nil

Company Secretary (unnamed in reviewed sources), age 56

Corporate Secretary

Appointed ~18–19 Jan 2024

———

Executive Leadership Team

NameRoleDatesNotes

Michael Di Tommaso

Executive Director; CEO from 25 Jan 2021

Joined 2018 as Operations Manager – Cultivation; later COO; resigned 8 Aug 2022

BA Criminal Justice; JD (University of Ottawa). Base salary CAD 216,000. Granted 27M options (Dec 2021)

Adam Clode

CEO

1 Jul 2019 – 25 Jan 2021

Base CAD 216,000. Settled in 12,265,622 shares (31 May 2021); 8M performance rights lapsed or forfeited

Matthew O'Kane

NED

30 Nov 2020 – 19 Oct 2021

BEcFin, MBA (RMIT)

Leighton Richards

NED

19 Oct 2021 – 1 Mar 2022

MBA, MMktg (Monash)

Jamie Myers

NED

– 30 Nov 2020

Associate Director, Baker Young Stockbrokers

Michael Slater

Director

– 28 Feb 2020

—

Melanie Leydin

Company Secretary & CFO

– 30 Apr 2021

—

Karla Mallon

CFO

30 Apr 2021 – (n/d)

Chartered Accountant (Automic Group)

Andrew Palfreyman

Company Secretary

30 Apr 2021 – 5 May 2022

Corporate lawyer

Directors' Remuneration

NameYearCash salary/feesSuperannuationEquity-settledTotal

Michael Di Tommaso

FY2022

00135,500135,500

Terry Gardiner

FY2022

24,0002,400026,400

Leighton Richards

FY2022

17,6211,8252,90022,346

Matthew O'Kane

FY2022

14,3231,432015,755

Michael Carli

FY2022

000

0 (fees waived)

Peter Hatfull

FY2022

000

0 (fees waived)

Total KMP

FY2022

55,944

5,657

138,400

200,001

Adam Clode

FY2021

00542,866542,866

Michael Di Tommaso

FY2021

199,65300199,653

Michael Carli

FY2021

43,876029,55573,431

Terry Gardiner

FY2021

48,0004,560052,560

Total KMP

FY2021

319,529

7,220

592,421

919,170

Total KMP

FY2020

554,591

19,375

464,349

1,038,315

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning vs RotoGro

Rotary/orbital gardens

Omega Garden / Volksgarden (Canada)

Private

Closest technology analogue (rotary hydroponic carousels); longer commercial history

Rotary/orbital gardens

RavenQuest BioMed (Canada)

Formerly CSE-listed

Built "orbital gardens"; settled patent infringement in RotoGro's favour (FY2021)

Indoor vertical farming (operators/tech)

AeroFarms (USA)

Private

Large-scale aeroponic operator; public reports indicate a Chapter 11 filing in 2023

Indoor vertical farming

AppHarvest (USA)

Formerly NASDAQ

High-tech greenhouses; public reports indicate a Chapter 11 filing in 2023

Indoor vertical farming

Bowery Farming (USA)

Private

Public reports indicate it ceased operations in late 2024

Indoor vertical farming

Plenty Unlimited (USA)

Private

Public reports indicate a Chapter 11 filing in 2025

Indoor vertical farming

Infarm (Germany)

Private

Modular in-store farms; publicly reported retrenchment from 2022

Indoor farming tech

Affinor Growers (Canada, CSE)

Listed micro-cap

Vertical tower growing technology; similar micro-cap profile

Agtech micro-caps (ASX)

Roots Sustainable Agricultural Technologies (ASX: ROO)

Listed micro-cap

Root-zone temperature technology; shared director (Hatfull)

Cannabis cultivation equipment & supply

Hydrofarm Holdings (NASDAQ: HYFM)

Listed

Scale hydroponics equipment distributor/manufacturer

Cannabis cultivation equipment & supply

GrowGeneration (NASDAQ: GRWG)

Listed

Hydroponic retail/distribution

Cannabis cultivation equipment & supply

Hawthorne Gardening (Scotts Miracle-Gro)

Division of NYSE: SMG

Dominant branded hydroponic supplier

Fertigation / nutrients

Netafim (Orbia), Priva, Argus Controls

Corporate

Established fertigation and climate-control vendors versus the sub-scale Hanson line

Competitor Detail

MetricRotoGro (FY2021)

Revenue

A$0 (sales); A$1.14M peak (FY2019)

Growth

−100% (FY2021)

Gross margin

n/m (−52.8% FY2020)

R&D intensity

100% of sales

Recent Developments

Note on coverage: * The strict 18-month window (April 2025 – October 2026) contains only one verifiable event, because the company has been dormant and delisted since March 2024. To give a usable register, the table extends back to the start of the company's terminal phase (July 2021). Entries are in chronological order.

Company Snapshot

2015

Founded

Nedlands, Australia

Headquarters

SWOT Analysis

Strengths

  • Granted, defended IP. Canadian Patent 2,908,184 ownership was confirmed by Federal Court order in the RavenQuest settlement; Australian Patent 2015243012 was granted in FY2021.
  • Integrated stack. Hardware (Models 420 and 710), iGrow Enterprise Edition software, fertigation integration and AGVs were all developed in-house (FY2021 Annual Report).
  • Demonstrated yields. Company trials reported 7–9 lb of cannabis per system every 60 days (Nov 2018).
  • Headline commercial validation. A$10M Verity Greens TLA (Dec 2020); A$2.03M Canniberia agreement; CAD 380k Wolf Island order.
  • Debt-free balance sheet. Zero borrowings in every year, FY2020–FY2022.
  • Access to grant funding. A$519k of COVID-19 grants in FY2021, mainly the Canada Emergency Wage Subsidy.

Weaknesses

  • Revenue never scaled. Peak sales were A$1.14M (FY2019), followed by A$0 in FY2021 and A$27k in FY2022.
  • Negative unit economics. FY2020 gross loss of A$358k on A$679k of sales.
  • Chronic cash burn. Free cash flow of −A$4.59M, −A$3.11M and −A$2.26M in FY2020–FY2022.
  • Value destruction from M&A. Hanson dissolved after two years; Gibio investment written off (A$440k); Supra deal not evidenced as completed.
  • Governance weaknesses. No board committees; 55.8% remuneration vote (first strike); FY2022 audit disclaimer; accounts lodged 14 months late.
  • Equity-heavy remuneration. Share-based payments of A$900k in FY2021 against nil revenue.

Opportunities

  • Shell value. An ASX-registered entity with ≈A$37M of accumulated losses could have offered tax-loss value, but this was subject to continuity-of-ownership and same-business tests (FY2022 Note 8) and lost with the delisting.
  • IP monetisation. The patents might have been sold or licensed by the bankruptcy estate; the disposition is n/d.
  • CEA tailwinds. Food-security and water-efficiency themes, consistent with the Model 710's claimed lower water and power use.
  • Space agriculture. The NASA/CSA challenge entry showed possible adjacency.
  • European cannabis liberalisation. The Canniberia (Portugal) agreement gave a conditional entry point.
  • Recapitalisation or reverse takeover of the shell. The directors' going-concern note contemplated acquiring new assets.

Threats

  • Deregistration. ASIC strike-off action was initiated on 6 Aug 2026, which would extinguish the company and any residual shareholder value.
  • Loss of all operating assets. Every subsidiary was deconsolidated and A$1.197M of cash derecognised (FY2022 Note 7).
  • Counterparty failure risk. The Verity Greens and Canniberia agreements were conditional and never converted.
  • Industry bust. Multiple high-profile vertical-farming operators reportedly failed from 2023 to 2025.
  • Listing loss. Removed from the ASX on 1 Mar 2024, so there is no liquidity or ability to raise capital through ASX.
  • Creditor exposure. Customer deposits (A$751k of contract liabilities at deconsolidation) sit with the bankrupt subsidiary, a potential source of reputational or legal claims.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
7 Jul 2021CAD 380k Wolf Island Cannabis purchase-and-sale agreement (CAD 213k deposit)Last significant customer order
19–20 Jul 2021Shareholders approve 32.67M options; A$2.2M placement announced (EverBlu)Final meaningful capital raise
23 Jul 202162,857,143 placement shares issued at A$0.035—
30 Jul 202132,666,667 options issued (expiring 31 Dec 2023)Dilution overhang
9 Aug 2021NASA/CSA Deep Space Food Challenge Phase 1 entryPublicity / technology diversification
16 Aug 2021Class B Hanson performance shares lapseHanson earn-out unmet
30 Aug 2021Advisory Board formed (Merker, Kampian)Deal origination effort
31 Aug 2021FY2021 Annual Report: unmodified audit; going concern supported by budgeted "profitable" tradingManagement optimism later unfulfilled
2021 (date n/d)CSE dual-listing plan announcedNot executed
2021 (date n/d)Verity Greens amendment: up to 1,872 systems; deadline extended to 31 Dec 2022Signalled delay in the headline contract
15 Oct 2021IP holding entity re-domiciled Mauritius → BVIRestructuring of IP holding
19 Oct 2021O'Kane resigns; Richards appointed NEDBoard churn
Nov 2021 (AGM)Remuneration report receives only 55.8% support (first strike)Shareholder discontent
15–24 Dec 202127M options granted to CEO Di Tommaso; 1M to RichardsEquity-heavy pay at a A$0.021 share price
31 Dec 2021A$8.01M impairment of the cash-generating unit (half-year)Recognition of commercial failure
1 Jan 2022Effective deconsolidation date (last verifiable financial information)Loss of visibility over operations
~25 Feb 2022Last trade; shares suspendedEnd of liquidity for shareholders
1 Mar 2022Richards resigns as NED—
11 Mar 2022Options granted (pre-consolidation equivalent 62.86M at A$0.07; 3,142,857 post-consolidation at A$1.40, expiring 11 Mar 2024)July 2021 placement attaching options
19 Apr 2022Peter Hatfull appointed NEDRestructuring specialist joins
5 May 2022Palfreyman resigns as Company Secretary; Hatfull appointed—
31 May 2022Roto-Gro World Wide (Canada) Inc. files for bankruptcy; control of all subsidiaries lostTerminal event for the operating business
8 Aug 2022CEO Di Tommaso resignsLeadership vacuum
26 Sep 202251.39M shares issued at A$0.001 (A$51k)Emergency funding
3 Nov 2022General meeting approves 1:20 consolidationCapital restructure
14 Nov 2022Consolidation effective (19.70M shares)—
Nov–Dec 202210.62M pre-consolidation options (A$0.20) and 5M (A$0.03) expireOverhang reduces
31 Aug 2023FY2022 Annual Report lodged; auditor disclaimer; net liabilities A$13,128Confirms the shell status
31 Dec 2023Large tranches of options expire (e.g., 1,575,401 at A$1.00; 1,333,357 at A$1.20)—
18–19 Jan 2024New Corporate Secretary appointed (age 56; per MarketScreener)Administrative
22 Jan 2024Appendix 3H: cessation of expired performance rights and optionsClean-up of the capital register
31 Jan 2024Quarterly Activities / Appendix 4C lodgedLast known periodic disclosure
1 Mar 2024Removed from the ASX Official List (Listing Rule 17.12)Loss of listing
6 Aug 2026ASIC strike-off action initiatedLikely deregistration of the entity

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Sales revenue fell from AUD 0.5 Mn in FY2018 to AUD 0 Mn in FY2022.
Roto-Gro International Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2018FY2019FY2020FY2021FY2022
Sales revenue0.51.10.700
Cost of goods sold——-1-0-0.2
Gross profit——-0.4-0-0.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.